SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 94 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $905,113 | +9.7% | 239,448 | +94.4% | 0.00% | – |
| Q2 2023 | $825,125 | -35.5% | 123,153 | -37.3% | 0.00% | – |
| Q1 2023 | $1,279,241 | +32.8% | 196,504 | +74.1% | 0.00% | – |
| Q4 2022 | $962,994 | +83.1% | 112,895 | +13.3% | 0.00% | – |
| Q3 2022 | $526,000 | +0.6% | 99,652 | -19.2% | 0.00% | – |
| Q2 2022 | $523,000 | +46.5% | 123,286 | +21.2% | 0.00% | – |
| Q1 2022 | $357,000 | -31.5% | 101,691 | +30.0% | 0.00% | – |
| Q4 2021 | $521,000 | -4.1% | 78,233 | +43.9% | 0.00% | – |
| Q3 2021 | $543,000 | -86.7% | 54,349 | -38.1% | 0.00% | -100.0% |
| Q4 2020 | $4,069,000 | – | 87,813 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $15,168,773 | 7.77% |
| Nextech Invest Ltd. | 1,910,029 | $7,219,910 | 2.19% |
| K2 PRINCIPAL FUND, L.P. | 2,552,062 | $9,646,794 | 2.02% |
| Charles Schwab Trust Co | 4,246,071 | $16,050,148 | 1.81% |
| Sio Capital Management, LLC | 1,105,911 | $4,180,344 | 1.29% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $41,874,564 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 1,049,191 | $3,965,942 | 0.77% |
| Orbimed Advisors | 9,240,887 | $34,930,553 | 0.74% |
| RA Capital Management | 9,459,678 | $35,757,583 | 0.70% |
| K2 PRINCIPAL FUND, L.P. | 688,900 | $2,604,042 | 0.55% |